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 Abstract 
 Background/Aims: Calcium homeostasis requires regulat-
ed cellular and interstitial systems interacting to modulate 
the activity and movement of this ion. Disruption of these 
systems in the kidney results in nephrocalcinosis and neph-
rolithiasis, important medical problems whose pathogene-
sis is incompletely understood.  Methods: We investigated 
25 patients from 16 families with unexplained nephrocalci-
nosis and characteristic dental defects (amelogenesis im-
perfecta, gingival hyperplasia, impaired tooth eruption). To 
identify the causative gene, we performed genome-wide 
linkage analysis, exome capture, next-generation sequenc-
ing, and Sanger sequencing.  Results: All patients had bi-
allelic  FAM20A mutations segregating with the disease; 20 
different mutations were identified.  Conclusions: This au-
tosomal recessive disorder, also known as enamel renal
syndrome, of  FAM20A causes nephrocalcinosis and amelo-
genesis imperfecta. We speculate that all individuals with 
biallelic  FAM20A mutations will eventually show nephrocal-
cinosis.  Copyright © 2013 S. Karger AG, Basel 
 Introduction 
 Nephrocalcinosis (NC), diagnosed by radiographs, 
CT, or increased echogenicity on ultrasound, represents 
an important renal complication because it can accom-
pany progressive deterioration of glomerular function or 
nephrolithiasis  [1] . In some cases, NC provides a clue to 
an underlying genetic disorder such as hyperoxaluria or 
distal renal tubular acidosis with or without deafness  [2, 
3] . In other cases, NC is a side effect of chronic treatment 
with various drugs, including loop diuretics and vitamin 
D. In general, the pathogenesis of NC has not been ade-
quately elucidated, although hypercalciuria appears to be 
a common finding.
 Often, rare genetic diseases reveal previously unrecog-
nized mechanisms of action regarding physiology, cell bi-
ology, and metabolism. Here, we present genetic studies 
into a rare human disease of NC combined with amelo-
genesis imperfecta (AI), a disorder of abnormal enamel 
formation and impaired tooth eruption.
 Methods 
 Patients and families were identified in our rare disease renal 
tubular or dental/craniofacial reference centers and gave informed 
consent. This study was approved by the institutional review 
boards and ethics committees of the various centers. All patients 
had NC confirmed by either ultrasound, X-ray or CT, and all 
showed characteristic teeth findings with AI and delayed or miss-
ing tooth eruption.
 In short, multipoint parametric linkage analysis utilizing 2,000 
highly polymorphic markers (DeCode, Iceland) across the whole 
genome in 4 informative families as well as homozygosity mapping 
for another consanguineous family was used to determine the lo-
cus linked to this trait, as published before  [4, 5] . Next-generation 
sequencing using exome capture (Perkin Elmer, USA; Leeds 
Translational Genomics Unit, UK) was performed on 5 patients 
from 5 unrelated families; 4 were part of the linkage analysis. Sub-
sequent data analysis was restricted to novel sequence variants 
within the linked region. The frequency of each variant was exam-
ined in >100 ethnically matched alleles available in public data-
bases (1000 Genomes, release 12 – May 2012). Sanger sequencing 
was performed as described, and mutations were sequenced in 
family members for segregation analysis.
 In detail, genomic DNA was isolated from peripheral blood 
lymphocytes for all subjects using standard protocols. Genotypes 
from polymorphic markers for 4 families were generated by De-
Code, Iceland. Analyses were carried out as published before 
with modifications  [4] . In short, genotypes were examined using 
a multipoint parametric linkage analysis and haplotype recon-
struction was performed via Allegro and Genehunter for an au-
tosomal recessive model with complete penetrance, disease allele 
frequency of 0.001 (DeCode map with appropriate allele fre-
quencies). The data were formatted using Mega2 (version 4.0) 
through Alohomora (version 0.30, Win32); non-informative 
markers were filtered out. Mendelian inconsistencies were 
checked using PedCheck (version 1.1); unlikely genotypes were 
identified and filtered using Merlin (version 1.1 alpha 3). The 
Allegro haplotype output files were visualized with Haplopaint-
er. In addition and in parallel, whole-genome SNP microarray 
analysis was performed on genomic DNA for another consan-
guineous family by AROS Applied Technology; resulting data 
were analyzed using IBD finder software  [5] . Whole-exome se-
quencing was performed using 3 μg of genomic DNA, which was 
sheared and ligated to Illumina adapters, according to Agilent’s 
SureSelect Library Prep protocol. The sample was then size se-
lected (200–300 bp) by agarose gel electrophoresis and enriched 
for 12 cycles, using PCR prior to hybridization to the SureSelect 
reagent for 24 h at 65  °  C. The library was denatured using NaOH 
and diluted to a concentration of 12 p M , of which 120 μl was hy-
bridized onto a v5 single-read flow cell (Illumina, San Diego, 
Calif., USA). Samples were prepared for sequencing according 
to Illumina’s standard amplification, linearization, blocking and 
primer hybridization protocols. The flow cell was then loaded 
onto an Illumina GAIIx and sequencing performed for 80 cycles 
after which the raw data were processed using the Illumina pipe-
line. The data (qseq) files generated were aligned to the human 
reference sequence (hg19/GRCh37) using Novoalign short-read 
alignment software (Novocraft Technologies, Selangor, Malay-
sia). Duplicate reads and reads mapping to multiple locations 
were excluded from any analysis. SAMtools and the Genome 
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Analysis Toolkit were used to further process the alignment files 
for variant calling  [6, 7] .
 For confirmation of variants detected by exome capture/next-
generation sequencing and for mutation detection in additional 
cases, we amplified all coding exons and exon-intron boundaries 
of  FAM20A using standard PCR methodology with intronic (ge-
nomic) primers. PCR products were separated on 1% agarose gels 
with ethidium bromide using electrophoresis and visualized un-
der UV light. Specific bands were cut and DNA was isolated and 
purified using standard procedures. Bi-directional sequencing of 
all exons and exon-intron boundaries were performed using a 
Beckman Coulter CEQ8000 or an Applied Biosystems 3130xl 
capillary sequencer per the manufacturer’s protocol. Sequencing 
data was analyzed and compared with the published reference 
sequence for  FAM20A (NG_029809, April 2012, NCBI build 
37.3).
 Results 
 We ascertained 25 patients (12 males, 13 females; age 
12–64) in 16 families with NC and characteristic dental 
findings, i.e., the triad of AI, gingival thickening and im-
pairment of tooth eruption ( table 1 ). The diagnosis of NC 
was made predominantly by nephrologists based upon 
characteristic imaging findings. Generalized hypoplastic 
AI was evident from eruption of the deciduous teeth early 
in childhood with subsequent impaired eruption of the per-
manent teeth and development of gingival enlargement. 
Clinical details of some patients have been published  [8–
11] . None of the parents or offspring of our patients had AI.
 From the 16 families with this disorder, we selected 
four informative families ( fig.  1 A) for whole-genome 
Table 1.  FAM20A mutations in patients with NC and AI
Family Age, years Gender FAM20A mutations
1 21 male c.915–918delCTTT; p.F305fsX380
2 27 female IVS2 + 1G>A/c.913–914delTT; p.F305fsX378
31 male IVS2 + 1G>A/c.913–914delTT; p.F305fsX378
3 23 male IVS4 + 1G>C/c.1348–1349delTC; p.S450fsX469
25 female IVS4 + 1G>C/c.1348–1349delTC; p.S450fsX469
4 59 male c.1475–1482dupAACCCCAC; p.L495fsX509
64 female c.1475–1482dupAACCCCAC; p.L495fsX509
5 12 female c.406C>T; p.R136X
6 20 male c.34–35delCT; p.L12fsX78
7 16 female c.1513delA; p.I505fsX506
22 male c.1513delA; p.I505fsX506
8 20 male c.1432C>T; p.R478X
9 13 male c.518T>G; p.L173R
10 29 female c.727C>T/c.1228–1229delGA; p.R243X/p.D410fsX414
11 19 female c.217C>T/c.727C>T; p.R73X/p.R243X
20 male c.217C>T/c.727C>T; p.R73X/p.R243X
12 18 female c.1369A>T; p.K457X
13 14 female c.755–757delTCT/c.641–719del79bp; p.F252del/p.I214fsX259
16 male c.755–757delTCT/c.641–719del79bp; p.F252del/p.I214fsX259
14 21 female IVS5 + 2T>G
15 24 male c.907–908delAG; p.S303fsX378
31 male c.907–908delAG; p.S303fsX378
37 female c.907–908delAG; p.S303fsX378
16 17 female c.34–35delCT/c.612delC; p.L12fsX78/p.A204fsX215
18 female c.34–35delCT/c.612delC; p.L12fsX78/p.A204fsX215
 Mutations are described on the cDNA and predicted protein levels. Listing of one allele indicates homozygosity; two alleles indicate 
compound heterozygosity. Every patient had biallelic mutations involving insertions, deletions, essential splice sites, missense changes 
or nonsense changes.
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parametric multipoint linkage studies. Using dense
(2 cM) polymorphic markers, we identified a single linked 
locus on chromosome 17q24 with a LOD score of 3.1 
( fig.  1 B). Haplotype reconstruction placed the locus
between flanking markers D17S1821 (97.3 cM) and 
D17S1797 (106.2 cM), a region of 5.3 million bases con-
taining 41 annotated genes (NCBI build 37.3, October 
2011). Independently, homozygosity mapping identified 
the same locus in another consanguineous family (data 
not shown).
 To identify the disease-causing gene, we performed 
massive parallel sequencing using exome capture on 5 
unrelated patients. Using an autosomal recessive model, 
limiting our analysis to the linked region, and filtering 
variants to eliminate common polymorphisms, we 
found homozygous or compound heterozygous muta-
tions in all 5 patients in only one gene,  FAM20A . A total 
of 20 different mutations (deletions, insertions, and 
splice site, missense and nonsense mutations) were 
identified in the homozygous or compound heterozy-
gous state, confirmed by Sanger sequencing, and dem-
onstrated to  segregate with the disorder in our 16 fami-
lies ( table  1 ).  FAM20A (cDNA 1,626 bp, protein 541 
amino acids, 11 coding exons) is a member of a family 
of kinase-encoding genes that includes  FAM20B and 
 FAM20C . 
D
17S2200 EN
D
C17
D
G
17S14 D
17S668
D
17S745 D
17S784
D
17S1847 D
17S836
D
17S802 D
17S674
D
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D
17S1603 D
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D
17S1864 D
17S929
D
17S515 D
17S1862
D
17S1797 D
17S1351
D
17S949 D
17S1350
D
17S789 D
17S940
D
17S1874 D
17S1816
D
17S957 D
17S1290
D
17S787 D
17S1799
D
17S1795 D
17S1319
D
17S1859 D
17S1868
D
17S1299 D
17S1563
D
17S1818 D
17S1814
D
17S927 D
17S1867
D
17S1857 D
17S2196
D
17S969 D
17S1803
D
17S520 D
17S1303
D
17S945 D
17S804
D
17S952 D
17S1791
D
17S595 D
17S1832
D
17S919 D
17S1876
STARTC17 D
17S849
D
17S794 D
17S924 D
17S944
D
17S1821
D
17S916
D
17S788
D
17S1842
D
17S1293
D
17S2194
D
17S798
D
17S1800
D
17S1824
D
17S1871
D
17S918
D
17S839
D
17S922
D
17S799
D
17S1844
D
17S960
D
17S1854
D
17S831
D
17S2181
D
17S1529
cM
4.0
3.0
2.0
1.0
0
–1.0
–2.0
–3.0
–4.0
–5.0
–6.0
–7.0
–8.0
–9.0
–10.0
–11.0
–12.0
–13.0
–14.0
–15.0
–16.0
–17.0
–18.0
–19.0
LOD
A
B
 Fig. 1.  A Pedigrees used for multipoint 
parametric linkage analysis. Black symbols 
indicate affected, white unaffected, squares 
males and circles females.  B LOD score 
analysis for chromosome 17. Note the sin-
gle significant peak at 17q24. 
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 Discussion 
 Calcium plays many critical roles in human physiolo-
gy, serving as an intracellular messenger, an extracellular 
neuromuscular excitatory ion, and a structural compo-
nent of bone and teeth. For example, tooth enamel (cal-
cium hydroxyapatite) is the hardest human tissue and can 
function into old age, despite being the only mineralized 
tissue with no capacity for cellular repair. Hence, the tem-
poro-spatial concentration of calcium must be exquisite-
ly regulated in different compartments, bound to albu-
min within the circulation, sequestered by calbindin 
within cells, including teeth  [12] , and excreted under 
tight control by the kidney  [13] . Within the vasculature, 
calcium availability is closely modulated by an intricate 
interplay between bones and regulatory hormones that 
involves positive and negative feedback mechanisms 
(e.g., vitamin D, PTH, calcitonin)  [14, 15] . Consequences 
of dysregulated calcium homeostasis include nephrolithi-
asis and NC, i.e., precipitation of calcium in the urinary 
collecting system and renal interstitium, respectively.
 The processes that normally maintain calcium balance 
in renal tissues can be delineated by studying genetic dis-
orders involving NC. A prime example lies in an autoso-
mal recessive disorder of NC combined with AI. Linkage 
analysis and focused exome sequencing performed on af-
fected families identified the causative gene as FAM20A , 
previously associated only with a disorder of AI  [16, 17] .
 Previous causes of NC have involved epithelial and 
paracellular disturbances in calcium transport, predomi-
nantly caused by mutations in calcium-specific channels 
and proteins  [18–20] . These systems either reabsorb fil-
tered calcium from the filtrate (urine) across the renal 
tubular cell or release calcium from the tubular cell into 
the interstitial compartment. When they malfunction, in-
creased urinary calcium precipitates within the renal tu-
bule (leading to nephrolithiasis and urolithiasis) or with-
in the interstitium (leading to NC); this is invariably ac-
companied by hypercalciuria.
 Our 25 patients exhibited NC and AI, but ascertain-
ment of other patients with biallelic  FAM20A mutations 
will expand the phenotype and define the entire spectrum 
of this rare disease. Also, two different  Fam20a knock-out 
mouse models exhibited different findings; in one, no 
kidney findings were reported, whereas the other showed 
arterial calcification without NC  [21, 22] . The patients 
previously reported with  FAM20A mutations and AI may 
also prove to have NC.
 Conclusions 
 Our findings have implications for diagnosis and treat-
ment. FAM20A is a locally secreted protein with low 
abundance in saliva  [23] and blood  [24] , suggesting that 
replacement therapy could provide an option for a treat-
ment or prophylaxis.
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